COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.
Stay current on PCCA news and events, market trends, and all things compounding!
PCCA is proud to announce its updated USP<800> educational page. This new, streamlined experience offers answers to the questions PCCA has received regarding the new guidelines set for December 1, 2019.
Jeff Gloyer is an engineer I with Eagle. He has experience working with multidisciplinary teams to implement the engineering design process. Here he discusses considerations that compounding pharmacies need to take in order to ensure they are USP <797> and <800> compliant.
Daniel Banov talks about water activity in various products and why they are becoming increasingly important in the pharmacy compounding world.
On July 27, 2018, the Compounding Expert Committee of the United States Pharmacopeial Convention published proposed revisions to USP chapter <797> Pharmaceutical Compounding – Sterile Preparations. The proposed chapter is open to public comments until November 30, 2018, and is expected to become official on December 1, 2019.
On March 30, 2018, the Compounding Expert Committee of the United States Pharmacopeial Convention published proposed revisions to USP chapter <795> Pharmaceutical Compounding – Nonsterile Preparations. The revised chapter was open to public comments until July 31, 2018, and is expected to become official on December 1, 2019. Major revisions to the chapter include, but are not limited to, the following: